Prostaglandin receptor signalling and function in human endometrial pathology

Trends in Endocrinology and Metabolism

Volumn 15, Issue 8, 2004, Pages 398-404

  Jabbour, H N ^a   Sales, K J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYCLOOXYGENASE 3; CYCLOOXYGENASE 3 INHIBITOR; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; AUTOCRINE EFFECT; CANCER; CARCINOGENESIS; CELL MEMBRANE; CYCLIZATION; DYSMENORRHEA; ENDOMETRIAL DISEASE; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME MECHANISM; ENZYME SYNTHESIS; GENE DISRUPTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; MENORRHAGIA; NONHUMAN; OXYGENATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; ENDOMETRIUM; FEMALE; HUMANS; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; UTERINE DISEASES;

EID: 4544329567     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2004.08.006     Document Type: Review

References (65)

1. I. Morita Distinct functions of COX-1 and COX-2 Prostaglandins Other Lipid Mediat. 68/69 2002 165 175
2. N.V. Chandrasekharan COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression Proc. Natl. Acad. Sci. U. S. A. 99 2002 13926 13931
3. S. Narumiya Prostanoid receptors: structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
4. 2-biosynthetic pathway Prog. Lipid Res. 43 2004 3 35
5. 2 synthase that acts in concert with cyclooxygenase-2 J. Biol. Chem. 275 2000 32783 32792
6. K.J. Sales Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, PGE receptors and angiogenic factors by cyclooxygenase-1 Cancer Res. 62 2002 424 432
7. D. Hwang Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J. Natl. Cancer Inst. 90 1998 455 460
8. A. Kirschenbaum Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate Urology 56 2000 671 676
9. 2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors J. Lipid Res. 41 2000 873 881
10. K. Narko Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression J. Biol. Chem. 272 1997 21455 21460
11. P.C. Chulada Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice Cancer Res. 60 2000 4705 4708
12. T. Kitamura Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis Carcinogenesis 23 2002 1463 1466
13. M. Tsujii Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 1998 705 716
14. M. Tsujii, and R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
15. M. Tsujii Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc. Natl. Acad. Sci. U. S. A. 94 1997 3336 3340
16. R. Langenbach Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
17. G.A. Gross Opposing actions of prostaglandins and oxytocin determine the onset of murine labor Proc. Natl. Acad. Sci. U. S. A. 95 1998 11875 11879
18. R. Langenbach Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis Ann. N. Y. Acad. Sci. 889 1999 52 61
19. H. Lim Multiple female reproductive failures in cyclooxygenase 2-deficient mice Cell 91 1997 197 208
20. V.L. Schuster Molecular mechanisms of prostaglandin transport Annu. Rev. Physiol. 60 1998 221 242
21. V.L. Schuster Prostaglandin transport Prostaglandins Other Lipid Mediat. 68/69 2002 633 647
22. S.K. Banu Molecular cloning and spatio-temporal expression of the prostaglandin transporter: a basis for the action of prostaglandins in the bovine reproductive system Proc. Natl. Acad. Sci. U. S. A. 100 2003 11747 11752
23. 2α receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways J. Clin. Endocrinol. Metab. 89 2004 986 993
24. K.J. Sales Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes VEGF expression via cAMP-mediated transactivation of the EGF receptor and ERK1/2 signaling pathways Mol. Endocrinol. 18 2004 1533 1545
25. 2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor J. Biol. Chem. 278 2003 35451 35457
26. R. Pai Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors FASEB J. 17 2003 1640 1647
27. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nat. Med. 8 2002 289 293
28. B. McMahon Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation FASEB J. 16 2002 1817 1819
29. L.M. Luttrell Regulation of tyrosine kinase cascades by G-protein-coupled receptors Curr. Opin. Cell Biol. 11 1999 177 183
30. K.L. Pierce New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades Oncogene 20 2001 1532 1539
31. H. Daub A role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors Nature 379 1996 557 560
32. S. Kraus c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells J. Biol. Chem. 278 2003 32618 32630
33. K.J. Sales, and H.N. Jabbour Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium Reproduction 126 2003 559 567
34. H. Ota Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis Hum. Reprod. 16 2001 561 566
35. A.F. Haney Endometriosis-associated infertility Baillieres Clin. Obstet. Gynaecol. 7 1993 791 812
36. K.R. Bley The role of IP prostanoid receptors in inflammatory pain Trends Pharmacol. Sci. 19 1998 141 147
37. B.J. Tong Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-δ in human endometrial adenocarcinoma Neoplasia 2 2000 483 490
38. 2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors Br. J. Cancer 85 2001 1023 1031
39. G. Ferrandina Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome Cancer 95 2002 801 807
40. K. Subbaramaiah Inhibition of cyclooxygenase: a novel approach to cancer prevention Proc. Soc. Exp. Biol. Med. 216 1997 201 210
41. K. Watanabe Role of prostaglandin E receptor subtype EP1 in colon carcinogenesis Cancer Res. 59 1999 5093 5096
42. K. Watanabe Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice Cancer Lett. 156 2000 57 61
43. 2 increases growth and motility of colorectal carcinoma cells J. Biol. Chem. 276 2001 18075 18081
44. 2α in epithelial cell proliferation J. Clin. Endocrinol. Metab. 88 2003 1825 1832
45. 2 and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle J. Clin. Endocrinol. Metab. 86 2001 4453 4459
46. S. Battersby Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle Reproduction 127 2004 79 86
47. 2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway J. Clin. Endocrinol. Metab. 88 2003 4481 4487
48. J.W. Regan EP2 and EP4 prostanoid receptor signaling Life Sci. 74 2003 143 153
49. A.A. Templeton Prostaglandin concentrations in the semen of fertile men J. Reprod. Fertil. 52 1978 147 150
50. G. Kunz, and G. Leyendecker Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction Reprod. Biomed. Online 4 Suppl. 3 2002 5 9
51. S. Gutsche Seminal plasma induces mRNA expression of IL-1β, IL-6 and LIF in endometrial epithelial cells in vitro Mol. Hum. Reprod. 9 2003 785 791
52. 2 receptor expression and signalling in cervical adenocarcinoma cells Mol. Hum. Reprod. 8 2002 1065 1070
53. A. Ueno Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception Biochem. Pharmacol. 62 2001 157 160
54. 2-induced pain responses by use of EP1 and EP3 receptor knockout mice Br. J. Pharmacol. 133 2001 438 444
55. G.B. Perchick, and H.N. Jabbour COX-2 overexpression inhibits cathepsin D mediated cleavage of plasminogen to the potent anti-angiogenic factor angiostatin Endocrinology 144 2003 5322 5328
56. 2 J. Clin. Endocrinol. Metab. 87 2002 3928 3935
57. R.K. Jain, and M.F. Booth What brings pericytes to tumor vessels? J. Clin. Invest. 112 2003 1134 1136
58. 2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells Biochem. Biophys. Res. Commun. 306 2003 887 897
59. F. Sennlaub Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy Circulation 108 2003 198 204
60. T. Yamauchi The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer Anticancer Res. 23 2003 245 249
61. I. Nagatsuka Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer Int. J. Cancer 100 2002 515 519
62. K.L. Pierce Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton J. Biol. Chem. 274 1999 35944 35949
63. V. Capra Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation Eur. J. Pharmacol. 474 2003 149 159
64. H. Fujino Cellular conditioning and activation of β-catenin signaling by the FPB prostanoid receptor J. Biol. Chem. 277 2002 48786 48795
65. C.J. Torrance Combinatorial chemoprevention of intestinal neoplasia Nat. Med. 6 2000 1024 1028